Neurosurgery Professor Peter Thompson’s Stealth Biotech Silverback Therapeutics Raised $10M as Part of a $60M Round
Peter Thompson, a University of Washington neurosurgery professor and investor, co-founded stealth biotech Silverback Therapeutics which raised $10 million (part of a disclosed $60 million round) and lists staff with immunotherapy and oncology experience, though the company’s focus and co-founder remain undisclosed.